title: Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration.
authors.affiliation: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Kuti
authors.affiliation: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
authors.forename: Islam M
authors.initials: IM
authors.lastname: Ghazi
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Hartford Hospital, Hartford, CT, USA.
authors.forename: Richard
authors.initials: R
authors.lastname: Quintiliani
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Hartford Hospital, Hartford, CT, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Shore
authors.affiliation: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA; Division of Infectious Diseases, Department of Medicine, Hartford Hospital, Hartford, CT, USA. Electronic address: david.nicolau@hhchealth.org.
authors.forename: David P
authors.initials: DP
authors.lastname: Nicolau
mesh_terms: D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002511:Cephalosporins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D016638:Critical Illness; D024901:Drug Resistance, Multiple, Bacterial; D006440:Hemofiltration; D006801:Humans; D008297:Male; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D010949:Plasma / Q000737:chemistry; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification; D000078142:Tazobactam; D016896:Treatment Outcome; D014481:United States; D065093:beta-Lactamase Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000892:Anti-Infective Agents, Urinary; D002511:Cephalosporins; D065093:beta-Lactamase Inhibitors; C000594038:ceftolozane, tazobactam drug combination; D010397:Penicillanic Acid; D000078142:Tazobactam